Published in:

01-10-2018 | Letter to the Editor

Medical, social, and economic consequences of type 2 diabetes therapy with medicinal products from the group of DPP-4i, SGLT-2i, and GLP-1 RA

Authors: Zornitsa Mitkova, Konstantin Mitov, Vasil Valov, Manoela Manova, Alexandra Savova, Maria Kamusheva, Dimitar Tcharaktchiev, Zhivko Angelov, Galia Angelova, Guenka Petrova

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2018